Joshua Isner Sells 25,811 Shares of Axon Enterprise, Inc. (NASDAQ:AXON) Stock

Axon Enterprise, Inc. (NASDAQ:AXON) President Joshua Isner sold 25,811 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the transaction, the president now directly owns 228,166 shares in the company, valued at $82,103,253.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Axon Enterprise Stock Performance

Axon Enterprise stock traded down $5.04 during trading hours on Tuesday, hitting $359.35. The stock had a trading volume of 324,389 shares, compared to its average volume of 518,497. Axon Enterprise, Inc. has a fifty-two week low of $189.12 and a fifty-two week high of $378.89. The company has a market cap of $27.16 billion, a PE ratio of 105.07, a price-to-earnings-growth ratio of 9.50 and a beta of 0.94. The company has a 50-day moving average of $334.23 and a two-hundred day moving average of $312.76. The company has a quick ratio of 2.52, a current ratio of 2.88 and a debt-to-equity ratio of 0.35.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, beating analysts’ consensus estimates of $1.02 by $0.18. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The business had revenue of $504.00 million during the quarter, compared to analyst estimates of $478.35 million. During the same period in the prior year, the company posted $0.80 earnings per share. Axon Enterprise’s revenue was up 34.5% on a year-over-year basis. On average, equities research analysts anticipate that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

Hedge Funds Weigh In On Axon Enterprise

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. ICA Group Wealth Management LLC bought a new stake in Axon Enterprise in the fourth quarter valued at $26,000. Blue Trust Inc. grew its holdings in shares of Axon Enterprise by 987.5% in the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after purchasing an additional 79 shares during the last quarter. Trivant Custom Portfolio Group LLC bought a new position in Axon Enterprise during the 1st quarter valued at about $31,000. First PREMIER Bank acquired a new position in Axon Enterprise in the first quarter valued at about $33,000. Finally, Blue Bell Private Wealth Management LLC bought a new stake in Axon Enterprise during the first quarter worth about $41,000. 79.08% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have weighed in on AXON shares. Barclays upped their target price on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Northland Securities raised their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a research report on Thursday, August 8th. Jefferies Financial Group began coverage on shares of Axon Enterprise in a research report on Wednesday, July 17th. They issued a “buy” rating and a $385.00 target price for the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $400.00 price objective on shares of Axon Enterprise in a research note on Wednesday, August 7th. Finally, Craig Hallum increased their target price on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $361.15.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.